Abstract
Phytochemical investigation on the bark of Nauclea officinalis led to the isolation of a new monoterpenoid indole alkaloid, nauclediol. The structure of the compound was identified through extensive spectroscopic analysis. Nauclediol displayed cholinesterase-inhibitory activities towards AChE and BChE with IC50 values of 15.429 and 8.756 µM, respectively. Statistical analysis revealed that the mode of inhibition of nauclediol was non-competitive inhibitor for both AChE and BChE. Molecular docking revealed that nauclediol interacts with the choline-binding site and the catalytic triad of TcAChE and hBChE. This study also demonstrated the neuroprotective potential of nauclediol against amyloid beta-induced cytotoxicity and LPS-induced neuroinflammation activity in a dose-dependent manner.
Author supplied keywords
Cite
CITATION STYLE
Liew, S. Y., Mak, W. Q., Thew, H. Y., Khaw, K. Y., Hazni, H., Litaudon, M., & Awang, K. (2023). Neuroprotective Activities of New Monoterpenoid Indole Alkaloid from Nauclea officinalis. Processes, 11(3). https://doi.org/10.3390/pr11030646
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.